Evaluation of the Free Triiodothyronine/Free Thyroxine ratio and EuthyroidSick Syndrome in patients with COVID-19: A cross-sectional study
Authors:
- 1 December 2021
- journal article
- research article
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 12 (12) , 1343-1347
Abstract
Aim In our study, we aimed to evaluate the prevalence of euthyroid sick syndrome among patients with COVID-19, and the relationship between the possible change in free-triiodothyronine/free-thyroxine (fT3/fT4) ratio and the biochemical parameters used during the follow-up of COVID-19. Material and Methods A total of 114 sequential patients between 18-65 years of age, who were treated in the internal medicine service allocated to patients with COVID-19, were included in the study. fT3, fT4, thyroid-stimulating hormone (TSH), thyroid peroxidase antibodies, and thyroglobulin antibodies antibody levels were analyzed. fT3/fT4 ratio was calculated. Results According to the results, only isolated low fT3 levels were found in 39.5% (45/114) of the patients, while 25.4% (29/114) had both low TSH and fT3 levels, 31.6% (36/114) had autoimmune thyroid disease, and 3.5% (4/114) had normal results in the thyroid function tests. The fT3/fT4 ratio was also determined to be low in all groups. However, no significant correlation was found between the low fT3/fT4 ratio and the parameters used in monitoring COVID-19. Conclusion We believe that studies with a wider scope of participants are needed for testing the reduction in fT3/fT4 ratio with other biochemical parameters in patients with COVID-19 and without known thyroid disease.Keywords
This publication has 18 references indexed in Scilit:
- Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignanciesJournal of Translational Medicine, 2021
- The cytokine storm and thyroid hormone changes in COVID-19Journal of Endocrinological Investigation, 2021
- Impact of COVID-19 on the thyroid gland: an updateReviews in Endocrine and Metabolic Disorders, 2020
- Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19The Journal of Clinical Endocrinology & Metabolism, 2020
- How COVID-19 induces cytokine storm with high mortalityInflammation and Regeneration, 2020
- Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient managementAnnales d'Endocrinologie, 2020
- SARS-CoV-2-related atypical thyroiditisThe Lancet Diabetes & Endocrinology, 2020
- Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort studyBMC Cardiovascular Disorders, 2018
- Non-Thyroidal Illness in the ICU: A Syndrome with Different FacesThyroid®, 2014
- Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humansJournal of Clinical Investigation, 2005